Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Director departure
Quarterly results
CC transcript
|
|
BIO REFERENCE LABORATORIES INC (BRLI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/20/2015 |
8-K
| Quarterly results |
| 08/10/2015 |
8-K
| Other Events |
| 06/11/2015 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 06/10/2015 |
8-K
| Investor presentation |
| 06/08/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 06/08/2015 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 06/04/2015 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"Agreement and Plan of Merger among Bio-Reference Laboratories, Inc., OPKO Health, Inc. and Bamboo Acquisition, Inc",
"Employment Agreement among Bio-Reference Laboratories, Inc., OPKO Health, Inc. and Marc D. Grodman",
"Employment Agreement between Bio-Reference Laboratories, Inc. and Nicholas Papazicos",
"Ehxibit 99.1 OPKO Health to Acquire Bio-Reference Laboratories" |
|
| 05/20/2015 |
8-K
| Entry into a Material Definitive Agreement |
| 04/29/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/13/2015 |
8-K
| Other Events |
| 03/05/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/05/2015 |
8-K
| Quarterly results|
Docs:
|
"Three Months Ended January 31, January 31, 2015 2014 Net Revenues $ 208,833 $ 181,270 Cost of Sales 119,078 109,116 Gross Profit on Revenues 89,755 72,154 General and Administrative 77,827 66,274 Operating Income 11,928 5,880 Other Expense, Net 424 625 Income Before Taxes 11,504 5,255 Taxes 4,871 2,301 Net Income 6,633 2,954 Income Per Share $ 0.24 $ 0.11 Number of Shares 27,740,309 27,700,167 Income Per Share $ 0.24 $ 0.11 Number of Shares 27,867,214 27,848,492 Bio-Reference Laboratories, Inc. Balance Sheets / Audited January 31, October 31, 2015 2014 Cash & Cash Equivalents $ 22,240 $ 17,507 Accounts Receivable 268,720 263,346 Plant, Property & Equipment 65,642 66,388 Intangible Assets 49,110 49,588 Other Assets 82,431 82,034 Total $ 488,143 $ 478,863 Accounts Payable $ 68,030 $ 71,166 ..." |
|
| 12/18/2014 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits|
Docs:
|
"Three Months Ended October 31, 2014 2013 Net Revenues $ 227,594 $ 192,219 Cost of Sales 120,741 106,937 Gross Profit on Revenues 106,853 85,282 General and Administrative 76,058 64,835 Operating Income 30,795 20,447 Other Expense, Net 680 674 Income Before Taxes 30,115 19,773 Taxes 11,834 8,653 Net Income 18,281 11,120 Income Per Share $ 0.66 $ 0.40 Number of Shares 27,727,644 27,676,546 Income Per Share $ 0.66 $ 0.40 Number of Shares 27,869,113 27,843,719 Twelve Months Ended October 31, 2014 2013 Net Revenues $ 832,282 $ 715,354 Cost of Sales 462,283 392,815 Gross Profit on Revenues 369,999 322,539 General and Administrative 286,574 240,566 Operating Income 83,425 81,973 Other Expense, Net 2,458 876 Income Before Taxes 80,967 81,097 Taxes 34,209 35,272 Net Income 46,758 45,825 Income Per ..." |
|
| 11/21/2014 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events |
| 08/27/2014 |
8-K
| Quarterly results|
Docs:
|
"Three Months Ended July 31, 2014 2013 Net Revenues $ 222,053 $ 185,427 Cost of Sales 119,610 99,767 Gross Profit on Revenues 102,443 85,660 General and Administrative 74,572 60,601 Operating Income 27,871 25,059 Other Expense, Net 513 Income Before Taxes 27,358 25,755 Taxes 12,108 11,054 Net Income 15,250 14,701 Income Per Share $ 0.55 $ 0.53 Number of Shares 27,721,977 27,671,880 Income Per Share $ 0.55 $ 0.53 Number of Shares 27,854,489 27,841,998 Nine Months Ended July 31, 2014 2013 Net Revenues $ 604,688 $ 523,136 Cost of Sales 341,542 285,878 Gross Profit on Revenues 263,146 237,258 General and Administrative 210,516 175,731 Operating Income 52,630 61,527 Other Expense, Net 1,778 203 Income Before Taxes 50,852 61,324 Taxes 22,375 26,620 Net Income 28,477 34,704 Income Per Share $ 1.03..." |
|
| 07/17/2014 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 06/05/2014 |
8-K
| Quarterly results|
Docs:
|
"Three Months Ended April 30, 2014 2013 Net Revenues $ 201,366 $ 176,452 Cost of Sales 112,817 95,776 Gross Profit on Revenues 88,549 80,676 General and Administrative 69,670 59,967 Operating Income 18,879 20,709 Other Expense, Net 641 514 Income Before Taxes 18,238 20,195 Taxes 7,965 8,857 Net Income 10,273 11,338 Income Per Share $ 0.37 $ 0.41 Number of Shares 27,716,644 27,698,146 Income Per Share $ 0.37 $ 0.41 Number of Shares 27,857,467 27,879,448 Six Months Ended April 30, 2014 2013 Net Revenues $ 382,635 $ 337,709 Cost of Sales 221,932 186,111 Gross Profit on Revenues 160,703 151,598 General and Administrative 135,943 115,130 Operating Income 24,760 36,468 Other Expense, Net 1,266 899 Income Before Taxes 23,494 35,569 Taxes 10,267 15,566 Net Income 13,227 20,003 Income Per Share $ 0...." |
|
| 06/04/2014 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits |
| 03/04/2014 |
8-K
| Quarterly results|
Docs:
|
"Three Months Ended January 31, January 31, 2014 2013 Net Revenues $ 181,270 $ 161,256 Cost of Sales 109,116 90,334 Gross Profit on Revenues 72,154 70,922 General and Administrative 66,274 55,163 Operating Income 5,880 15,759 Other Expense, Net 625 386 Income Before Taxes 5,255 15,373 Taxes 2,301 6,708 Net Income 2,954 8,665 Income Per Share $ 0.11 $ 0.31 Number of Shares 27,700,167 27,716,336 Income Per Share $ 0.11 $ 0.31 Number of Shares 27,848,492 27,912,327 Bio-Reference Laboratories, Inc. Balance Sheets January 31, October 31, 2014 2013 Cash & Cash Equivalents $ 14,533 $ 17,952 Accounts Receivable 217,741 206,261 Plant, Property & Equipment 67,113 65,649 Intangible Assets 51,276 51,505 Other Assets 76,973 80,161 Total $ 427,636 $ 421,528 Accounts Payable $ 64,055 $ 61,614 Revolving N..." |
|
| 12/19/2013 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits|
Docs:
|
"Three Months Ended October 31, Reported) 2013 2012 2012 Net Revenues $ 192,219 $ 163,487 $ 176,052 Cost of Sales 106,937 88,806 88,807 Gross Profit on Revenues 85,282 74,681 87,245 General and Administrative 64,835 51,278 63,842 Operating Income 20,447 23,403 23,403 Other Expense, Net 674 437 437 Income Before Taxes 19,773 22,966 22,966 Taxes 8,653 10,077 10,077 Net Income 11,120 12,889 12,889 Income Per Share $ 0.40 $ 0.47 $ 0.47 Number of Shares 27,676,546 27,704,715 27,704,715 Income Per Share $ 0.40 $ 0.46 $ 0.46 Number of Shares 27,843,719 27,906,191 27,906,191 Twelve Months Ended October 31, Reported) 2013 2012 2012 Net Revenues 715,354 614,255 661,661 Cost of Sales 392,815 337,644 337,644 Gross Profit on Revenues 322,539 276,611 324,017 General and Administrative 240,566 200,480 247...",
"Prepared Comments of Company for December 19, 2013 Conference Call" |
|
| 11/27/2013 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 08/29/2013 |
8-K
| Form 8-K - Current report |
| 06/06/2013 |
8-K
| Quarterly results|
Docs:
|
"Reported) 2013 2012 2012 Net Revenues $ 176,452 $ 151,443 $ 163,388 Cost of Sales 95,776 83,909 83,909 Gross Profit on Revenues 80,676 67,534 79,479 General and Administrative 59,967 50,763 62,708 Operating Income 20,709 16,771 16,771 Other Expense, Net 514 370 370 Income Before Taxes 20,195 16,401 16,401 Taxes 8,857 7,095 7,095 Net Income 11,338 9,306 9,306 Income Per Share $ 0.41 $ 0.34 $ 0.34 Number of Shares 27,698,146 27,684,715 27,684,715 Income Per Share $ 0.41 $ 0.33 $ 0.33 Number of Shares 27,879,448 27,877,697 27,877,697 Six Months Ended April 30, Reported) 2013 2012 2012 Net Revenues $ 337,709 $ 290,236 $ 313,307 Cost of Sales 186,111 162,584 162,584 Gross Profit on Revenues 151,598 127,652 150,723 General and Administrative 115,130 97,597 120,668 Operating Income 36,468 30,055 ..." |
|
| 02/28/2013 |
8-K
| Quarterly results|
Docs:
|
"Reported) 2013 2012 2012 Net Revenues $ 161,256 $ 138,793 $ 149,919 Cost of Sales 90,334 78,676 78,676 Gross Profit on Revenues 70,922 60,117 71,243 General and Administrative 55,163 46,835 57,961 Operating Income 15,759 13,282 13,282 Other Expense, Net 386 316 316 Income Before Taxes 15,373 12,966 12,966 Taxes 6,708 5,601 5,601 Net Income 8,665 7,365 7,365 Income Per Share $ 0.31 $ 0.26 $ 0.26 Number of Shares 27,716,336 27,887,717 27,887,717 Income Per Share $ 0.31 $ 0.26 $ 0.26 Number of Shares 27,912,327 28,041,022 28,041,022 3 Bio-Reference Laboratories, Inc. Balance Sheets January 31, October 31, 2013 2012 Cash & Cash Equivalents $ 26,316 $ 25,143 Accounts Receivable 161,289 153,247 Plant, Property & Equipment 51,569 50,440 Intangible Assets 36,235 29,731 Other Assets 55,236 54,264 ..." |
|
| 02/25/2013 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 01/04/2013 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 12/27/2012 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 12/06/2012 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits|
Docs:
|
"Three Months Ended October 31, 2012 2011 Net Revenues $ 176,052 $ 151,297 Cost of Sales 88,807 76,384 Gross Profit on Revenues 87,245 74,913 General and Administrative 63,842 55,578 Operating Income 23,403 19,335 Other Expense, Net 437 481 Income Before Taxes 22,966 18,854 Taxes 10,077 8,378 Net Income 12,889 10,476 Income Per Share $ 0.47 $ 0.37 Number of Shares 27,704,715 27,948,567 Income Per Share $ 0.46 $ 0.37 Number of Shares 27,906,191 28,138,047 Twelve Months Ended October 31, 2012 Pro Forma 2011*** Actual 2011 Net Revenues $ 661,661 $ 558,642 $ 558,642 Cost of Sales 337,644 287,853 287,853 Gross Profit on Revenues 324,017 270,789 270,789 General and Administrative 247,886 211,015 211,015 Operating Income 76,131 59,774 59,774 Other Expense, Net 1,615 1,584 Income Before Taxes 74,51..." |
|
| 08/30/2012 |
8-K
| Quarterly results|
Docs:
|
"Three Months Ended July31, 2012 2011 Net Revenues $ 172,302 $ 148,029 Cost of Sales 86,253 74,597 Gross Profit on Revenues 86,049 73,432 General and Administrative 63,375 55,023 Operating Income 22,674 18,409 Other Expense, Net 492 416 Income Before Taxes 22,182 17,993 Taxes 9,586 7,912 Net Income 12,596 10,081 Income Per Share $ 0.45 $ 0.36 Number of Shares 27,695,215 27,941,233 Income Per Share $ 0.45 $ 0.36 Number of Shares 27,887,765 28,147,179 Nine Months Ended July 31, 2012 Pro Forma 2011*** Actual 2011 Net Revenues $ 485,609 $ 407,345 $ 407,345 Cost of Sales 248,837 211,469 211,469 Gross Profit on Revenues 236,772 195,876 195,876 General and Administrative 184,044 155,437 155,437 Operating Income 52,728 40,439 40,439 Other Expense, Net 1,179 1,103 Income Before Taxes 51,549 39,336 4..." |
|
| 08/07/2012 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 06/15/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/07/2012 |
8-K
| Form 8-K - Current report |
| 05/01/2012 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 03/22/2012 |
8-K
| Form 8-K - Current report |
|
|
|